ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

NCI To Conduct Survey On Needs For Compliance with Biohazard Requirements

December 16, 1977

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994